N@N

ALBANY MOLECULAR RESEARCH (NASDAQ:AMRI), Down By 13.07% ($0.40) From $3.060 After BUYINS.NET Report Predicted Weakness After Ea

^{Published on 2012-03-06 09:40:36 - WOPRAI}
 

March 6, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Monday, February 6th 2012 stating that ALBANY MOLECULAR RESEARCH (NASDAQ:AMRI) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=amri&id=240007

At the time this story was written, ALBANY MOLECULAR RESEARCH (NASDAQ:AMRI) is Down By 13.07% ($0.40) From $3.060 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

ALBANY MOLECULAR RESEARCH (NASDAQ:AMRI) - Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States, Europe, and Asia. The company offers drug discovery services, including assay development and design; screening programs, which provide tools to identify active compounds during the lead discovery phases of drug discovery; screening libraries for screening and hit-to-lead programs; bioanalytical services for extraction and quantitation of drug and metabolites in biological fluids and tissues; and natural product services. Its drug discovery services also include medicinal chemistry; computer-aided drug discovery services to identify novel hits or leads against selected therapeutic targets, as well as to support medicinal chemistry lead optimization programs; and in vitro ADMET assays to evaluate and improve metabolism, bioavailability, pharmacology, and toxicology of compounds. The company also provides chemical development services, such as process research and development; custom synthesis; process safety assessment; high potency and controlled substances; preparative chromatography; IND support services; fermentation development and optimization; and building blocks collection and database, as well as offers chemical synthesis and manufacturing services in accordance with cGMP regulations, and formulation services. In addition, it provides analytical services, including impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; and regulatory support, as well as offers chemical synthesis and manufacturing services. The company also serves agricultural and fine chemical companies, contract chemical manufacturers, government research entities, and non-profit organizations. Albany Molecular Research was founded in 1991 and is based in Albany, New York.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. ALBANY MOLECULAR RESEARCH (NASDAQ:AMRI) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net